| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
731,500,000 |
| Market
Cap: |
333.83(M) |
| Last
Volume: |
141,003 |
Avg
Vol: |
140,615 |
| 52
Week Range: |
$0.4199 - $1.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Northwest Biotherapeutics is a biotechnology company focused on developing personalized immune therapies for cancer. Co. has developed a platform technology, DCVax®, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. Co.'s primary product, DCVax®-L, is designed to treat solid tumor cancers in which the tumor can be surgically removed. This product is in a 331-patient Phase III trial for newly diagnosed Glioblastome multiforme. Co.'s second product, DCVax®-Direct, is designed to treat inoperable solid tumors. Co. is working on preparations for Phase II trials of DCVax-Direct in various cancers, when resources permit.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
570,000 |
570,000 |
| Total Sell Value |
$0 |
$0 |
$469,430 |
$469,430 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hemphill Robert F Jr. |
10% Owner |
– – • |
2011-10-28 |
4 |
OE |
$0.27 |
$544,500 |
I/I |
2,016,667 |
9,104,913 |
|
- |
|
| Boynton Alton L |
Chief Scientific Officer |
• • – |
2011-09-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
210,935 |
2,894,091 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2011-04-07 |
4/A |
GD |
$0.00 |
$0 |
D/D |
950,000 |
48,774,998 |
|
- |
|
| Boynton Alton L |
Chief Executive Officer |
• • – |
2011-03-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
1,975,440 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2011-02-02 |
4 |
S |
$1.08 |
$928,800 |
I/I |
(860,000) |
7,088,246 |
|
- |
|
| Boynton Alton L |
Chief Executive Officer |
• • – |
2010-12-17 |
4 |
A |
$0.61 |
$148,494 |
D/D |
243,432 |
2,410,866 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2010-10-09 |
4 |
D |
$0.17 |
$20,400 |
I/I |
(120,000) |
7,948,246 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2010-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
12,866,324 |
12,866,324 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2010-09-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(19,299,486) |
0 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-09-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
950,000 |
32,840,177 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2010-08-12 |
4 |
D |
$0.62 |
$1,395,000 |
I/I |
(2,250,000) |
8,068,246 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2010-07-31 |
4 |
B |
$0.20 |
$1,693 |
I/I |
8,466 |
10,318,246 |
1.42 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2010-07-02 |
4 |
A |
$0.75 |
$650,000 |
I/I |
866,667 |
3,439,377 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-07-02 |
4 |
S |
$0.75 |
$650,000 |
D/D |
(866,667) |
33,790,177 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-15 |
4 |
S |
$0.87 |
$34,842 |
D/D |
(40,048) |
32,923,510 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-14 |
4 |
S |
$0.91 |
$6,370 |
D/D |
(7,000) |
32,963,558 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-11 |
4 |
S |
$0.90 |
$180,000 |
D/D |
(200,000) |
32,970,558 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-10 |
4 |
S |
$0.93 |
$217,203 |
D/D |
(233,552) |
33,170,558 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-09 |
4 |
S |
$0.82 |
$16,400 |
D/D |
(20,000) |
33,404,110 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-07 |
4 |
S |
$0.93 |
$73,470 |
D/D |
(79,000) |
33,424,110 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-04 |
4 |
S |
$0.89 |
$26,700 |
D/D |
(30,000) |
33,503,110 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-02 |
4 |
S |
$0.97 |
$31,525 |
D/D |
(32,500) |
33,533,110 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-06-01 |
4 |
S |
$1.01 |
$7,979 |
D/D |
(7,900) |
33,565,610 |
|
- |
|
| Powers Linda F |
Director |
– • • |
2010-05-28 |
4 |
S |
$1.03 |
$103,000 |
D/D |
(100,000) |
33,573,510 |
|
- |
|
| Boynton Alton L |
Chief Executive Officer |
• • – |
2010-05-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
260,007 |
1,875,129 |
|
- |
|
112 Records found
|
|
Page 3 of 5 |
|
|
